Sales forecast of major cannabis pharmaceutical products by world region 2023-2027

Sales forecast of major pharmaceutical cannabis products worldwide from 2023 to 2027, by region

Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

August 2023

Region

Worldwide

Survey time period

as of June 2023

Supplementary notes

This graph includes sales forecasts of cannabis pharmaceutical products Epidiolex, Dronabinol, and Sativex. Products with insignificant sales are excluded.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Medical cannabis in the U.S. "

Other statistics that may interest you Medical cannabis in the U.S.

Overview

8

Companies

5

Cannabidiol

5

Focus: Colorado

6

Focus: Oregon

5

Patients and opinions

4
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.